Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza A (H1N1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01032395
What this trial is testing

Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus

Who this might be right for
H1N1 Influenza VirusChronic Pulmonary DiseaseChronic Heart Disease+1 more
Chiltern Pesquisa Clinica Ltda 342
Not applicableStudy completedNCT00985582
What this trial is testing

Antiviral Therapy for Influenza A H1N1

Who this might be right for
Influenza A Virus Infection
South East Asia Infectious Disease Clinical Research Network 181
Post-approval studies (Phase 4)Study completedNCT02143882
What this trial is testing

A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).

Who this might be right for
Live Attenuated Influenza Vaccine
Public Health England 300
Testing effectiveness (Phase 2)Study completedNCT01258023
What this trial is testing

Seasonal Flu Vaccine in Adult Transplant Recipients

Who this might be right for
ImmunocompromisedTransplanted
HepNet Study House, German Liverfoundation 122
Testing effectiveness (Phase 2)Study completedNCT03180801
What this trial is testing

Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model

Who this might be right for
Influenza
PepTcell Limited 153
Large-scale testing (Phase 3)Study completedNCT01201902
What this trial is testing

Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine

Who this might be right for
Influenza Infection
Green Cross Corporation 592
Not applicableStudy completedNCT01032980
What this trial is testing

Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults

Who this might be right for
InfluenzaSwine-Origin A/H1N1 Influenza Virus
Sanofi Pasteur, a Sanofi Company 3,934
Testing effectiveness (Phase 2)Study completedNCT01086904
What this trial is testing

Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients

Who this might be right for
Renal Transplant RecipientsImmunosuppression
Institut National de la Santé Et de la Recherche Médicale, France 122
Not applicableStudy completedNCT01066169
What this trial is testing

Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza

Who this might be right for
HIV
Leiden University Medical Center 104
Post-approval studies (Phase 4)Study completedNCT01246999
What this trial is testing

Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

Who this might be right for
Influenza
University of Rochester 34
Not applicableStudy completedNCT01484522
What this trial is testing

Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth

Who this might be right for
HIV-1 InfectionH1N1Influenza+1 more
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 149
Testing effectiveness (Phase 2)Study completedNCT01024400
What this trial is testing

Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women

Who this might be right for
Influenza
Institut National de la Santé Et de la Recherche Médicale, France 110
Not applicableStudy completedNCT01083511
What this trial is testing

Collection and Extraction of Respiratory Specimens

Who this might be right for
Influenza
QIAGEN Gaithersburg, Inc 600
Testing effectiveness (Phase 2)Study completedNCT00943631
What this trial is testing

Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 406
Large-scale testing (Phase 3)Study completedNCT06385821
What this trial is testing

Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

Who this might be right for
InfluenzaInfluenza AInfluenza, Human+8 more
NPO Petrovax 824
Testing effectiveness (Phase 2)WithdrawnNCT01037634
What this trial is testing

Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT01971255
What this trial is testing

Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 74
Testing effectiveness (Phase 2)Study completedNCT00943202
What this trial is testing

Sanofi Pasteur, TIV + H1N1, Pediatric Population

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 531
Testing effectiveness (Phase 2)Study completedNCT01336166
What this trial is testing

The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine

Who this might be right for
Influenza
Shanghai Institute Of Biological Products 480
Early research (Phase 1)Study completedNCT01177202
What this trial is testing

Study of the Safety and Immunogenicity of H1N1 Vaccine

Who this might be right for
H1N1 Flu
Fraunhofer, Center for Molecular Biotechnology 80
Next Page